Change in gait speed and adverse outcomes in patients with idiopathic pulmonary fibrosis: A prospective cohort study.
Claire Marie NolanSusie J SchofieldMaddocks MatthewSuhani PatelRuth E BarkerJessica A WalshOliver PolgarPeter M GeorgePhilip L MolyneauxToby M MaherPaul CullinanWilliam D-C ManPublished in: Respirology (Carlton, Vic.) (2023)
In newly diagnosed IPF, a substantial 4MGS decline over 6 months is associated with shorter time to hospitalization/death at 6 months. 4MGS change has potential as a surrogate endpoint for interventions aimed at modifying hospitalization/death.